Akums Drugs and Pharmaceuticals Limited

NSEI:AKUMS Stock Report

Market Cap: ₹90.2b

Akums Drugs and Pharmaceuticals Management

Management criteria checks 2/4

Akums Drugs and Pharmaceuticals' CEO is Sanjeev Jain, appointed in Apr 2004, has a tenure of 20.67 years. directly owns 17.26% of the company’s shares, worth ₹15.56B. The average tenure of the management team and the board of directors is 2.5 years and 2.8 years respectively.

Key information

Sanjeev Jain

Chief executive officer

₹54.2m

Total compensation

CEO salary percentagen/a
CEO tenure20.7yrs
CEO ownership17.3%
Management average tenure2.5yrs
Board average tenure2.8yrs

Recent management updates

Recent updates

CEO

Sanjeev Jain (58 yo)

20.7yrs

Tenure

₹54,220,000

Compensation

Mr. Sanjeev Jain is Co-Founder of Akums Drugs and Pharmaceuticals Limited in April 19, 2004 and serves as its Managing Director. He serves as Whole Time Director of Akums Drugs and Pharmaceuticals Limited...

Leadership Team

NamePositionTenureCompensationOwnership
Sanjeev Jain
Co-Founder20.7yrs₹54.22m17.26%
₹ 15.6b
Sandeep Jain
Co Founder20.7yrs₹53.67m17.24%
₹ 15.5b
Sumeet Sood
Chief Financial Officer2.8yrs₹22.47mno data
Sanjay Sinha
President of Operations & Whole Time Director2.1yrs₹2.10mno data
Dharamvir Malik
Company Secretary & Compliance Officerno data₹2.68mno data
Arvind Srivastava
President of Human Resource2yrsno datano data
Sanjay Sharma
President of Strategy3yrsno datano data
Amrut Medhekar
Chief Executive Officer - CDMO Businessless than a yearno datano data
Shantanu Chobhe
Corporate Quality Assurance Headless than a yearno datano data
Jitendra Mishra
Vice President of Information Technology of PCHLno datano datano data
Sunil Jaiswal
Vice President of Research and Developmentno datano datano data
Ashish Sharma
Vice President of Environmentalno datano datano data

2.5yrs

Average Tenure

58yo

Average Age

Experienced Management: AKUMS's management team is considered experienced (2.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Sanjeev Jain
Co-Founder20.7yrs₹54.22m17.26%
₹ 15.6b
Sandeep Jain
Co Founder20.7yrs₹53.67m17.24%
₹ 15.5b
Sanjay Sinha
President of Operations & Whole Time Directorless than a year₹2.10mno data
Kewal Handa
Independent Director2.8yrs₹3.00mno data
Sunil Thakur
Non-Executive Directorless than a yearno datano data
Matangi Gowrishankar
Independent Director2.8yrs₹2.80mno data
Satwinder Singh
Independent Directorless than a year₹500.00kno data
Nand Kalra
Independent Director12.5yrs₹1.16mno data

2.8yrs

Average Tenure

63yo

Average Age

Experienced Board: AKUMS's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 03:45
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Akums Drugs and Pharmaceuticals Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution